Portage Biotech (PRTG) Competitors $4.56 -0.01 (-0.22%) (As of 02:00 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PRTG vs. MEIP, FNCH, CGTX, BFRG, PRPH, NNVC, FLGC, ENLV, BGXX, and MRNSShould you be buying Portage Biotech stock or one of its competitors? The main competitors of Portage Biotech include MEI Pharma (MEIP), Finch Therapeutics Group (FNCH), Cognition Therapeutics (CGTX), Bullfrog AI (BFRG), ProPhase Labs (PRPH), NanoViricides (NNVC), Flora Growth (FLGC), Enlivex Therapeutics (ENLV), Bright Green (BGXX), and Marinus Pharmaceuticals (MRNS). These companies are all part of the "pharmaceutical products" industry. Portage Biotech vs. MEI Pharma Finch Therapeutics Group Cognition Therapeutics Bullfrog AI ProPhase Labs NanoViricides Flora Growth Enlivex Therapeutics Bright Green Marinus Pharmaceuticals MEI Pharma (NASDAQ:MEIP) and Portage Biotech (NASDAQ:PRTG) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership. Do insiders and institutionals have more ownership in MEIP or PRTG? 52.4% of MEI Pharma shares are held by institutional investors. Comparatively, 13.4% of Portage Biotech shares are held by institutional investors. 3.9% of MEI Pharma shares are held by company insiders. Comparatively, 42.1% of Portage Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more volatility and risk, MEIP or PRTG? MEI Pharma has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Portage Biotech has a beta of 1.59, indicating that its share price is 59% more volatile than the S&P 500. Does the MarketBeat Community believe in MEIP or PRTG? MEI Pharma received 386 more outperform votes than Portage Biotech when rated by MarketBeat users. Likewise, 61.96% of users gave MEI Pharma an outperform vote while only 59.09% of users gave Portage Biotech an outperform vote. CompanyUnderperformOutperformMEI PharmaOutperform Votes39961.96% Underperform Votes24538.04% Portage BiotechOutperform Votes1359.09% Underperform Votes940.91% Do analysts recommend MEIP or PRTG? MEI Pharma currently has a consensus price target of $7.00, indicating a potential upside of 145.61%. Portage Biotech has a consensus price target of $120.00, indicating a potential upside of 2,531.58%. Given Portage Biotech's higher possible upside, analysts clearly believe Portage Biotech is more favorable than MEI Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MEI Pharma 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Portage Biotech 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is MEIP or PRTG more profitable? MEI Pharma's return on equity of -84.80% beat Portage Biotech's return on equity.Company Net Margins Return on Equity Return on Assets MEI PharmaN/A -84.80% -65.24% Portage Biotech N/A -137.65%-92.21% Does the media prefer MEIP or PRTG? In the previous week, MEI Pharma had 1 more articles in the media than Portage Biotech. MarketBeat recorded 2 mentions for MEI Pharma and 1 mentions for Portage Biotech. MEI Pharma's average media sentiment score of 0.00 equaled Portage Biotech'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MEI Pharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Portage Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings & valuation, MEIP or PRTG? MEI Pharma has higher revenue and earnings than Portage Biotech. MEI Pharma is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMEI Pharma$65.30M0.29$17.78M-$6.99-0.41Portage BiotechN/AN/A-$75.34M-$46.19-0.10 SummaryMEI Pharma beats Portage Biotech on 9 of the 13 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRTG vs. The Competition Export to ExcelMetricPortage BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.79M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.105.5095.1214.22Price / SalesN/A375.021,217.3088.42Price / Cash0.5152.5939.4936.27Price / Book1.2210.276.976.37Net Income-$75.34M$153.22M$118.73M$225.56M7 Day Performance15.44%-1.19%-1.22%-0.02%1 Month Performance-21.78%-6.71%-3.07%2.04%1 Year Performance-84.28%32.39%32.52%28.00% Portage Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRTGPortage Biotech2.1495 of 5 stars$4.56-0.2%$120.00+2,531.6%-84.3%$4.79MN/A-0.106Upcoming EarningsGap UpMEIPMEI Pharma4.2134 of 5 stars$2.85+1.8%$7.00+145.6%-50.5%$18.98M$65.30M-0.40100FNCHFinch Therapeutics GroupN/A$11.45flatN/A+216.3%$18.43M$110,000.000.00190CGTXCognition Therapeutics2.5728 of 5 stars$0.44+0.6%$8.00+1,707.9%-57.7%$18.39MN/A-0.4520BFRGBullfrog AIN/A$2.10+4.0%N/A-36.3%$18.29M$60,000.000.004Gap UpPRPHProPhase Labs3.2606 of 5 stars$0.76-0.7%$11.00+1,348.3%-82.8%$18.13M$44.38M0.00130High Trading VolumeNNVCNanoViricidesN/A$1.29-3.0%N/A+15.8%$17.99MN/A-1.7420Analyst DowngradeFLGCFlora Growth2.2015 of 5 stars$1.33+9.0%$6.00+351.1%+22.0%$17.78M$76.07M0.00280Analyst RevisionNews CoverageENLVEnlivex Therapeutics3.075 of 5 stars$0.81-17.0%$6.00+640.6%-42.9%$17.34MN/A-0.7170News CoverageGap UpHigh Trading VolumeBGXXBright GreenN/A$0.09+5.4%N/A-78.4%$17.15MN/A-1.422News CoverageGap DownMRNSMarinus Pharmaceuticals4.4503 of 5 stars$0.31-0.3%$4.79+1,453.3%-95.0%$17.00M$30.99M-0.13110Analyst ForecastAnalyst RevisionGap Down Related Companies and Tools Related Companies MEI Pharma Alternatives Finch Therapeutics Group Alternatives Cognition Therapeutics Alternatives Bullfrog AI Alternatives ProPhase Labs Alternatives NanoViricides Alternatives Flora Growth Alternatives Enlivex Therapeutics Alternatives Bright Green Alternatives Marinus Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRTG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTG Stock Alerts